0
0

Securing Gene Synthesis Act

12/15/2023, 4:00 PM

Summary of Bill HR 4702

Bill 118 hr 4702, also known as the Securing Gene Synthesis Act, is a piece of legislation introduced in the US Congress. The main purpose of this bill is to regulate the synthesis of genes in order to prevent the misuse of this technology for harmful purposes, such as creating biological weapons.

The bill requires companies that provide gene synthesis services to screen orders for certain sequences that could be used to create dangerous pathogens or toxins. It also mandates that these companies verify the identity of their customers and report any suspicious orders to the Department of Health and Human Services.

Additionally, the bill establishes a framework for the government to work with industry stakeholders to develop best practices for gene synthesis security. This includes promoting information sharing and collaboration to address potential risks associated with gene synthesis technology. Overall, the Securing Gene Synthesis Act aims to balance the benefits of gene synthesis technology with the need to protect national security and public safety. It seeks to ensure that this powerful tool is used responsibly and ethically, while also fostering innovation and scientific progress.

Current Status of Bill HR 4702

Bill HR 4702 is currently in the status of Bill Introduced since July 18, 2023. Bill HR 4702 was introduced during Congress 118 and was introduced to the House on July 18, 2023.  Bill HR 4702's most recent activity was Referred to the Subcommittee on Health. as of July 21, 2023

Bipartisan Support of Bill HR 4702

Total Number of Sponsors
1
Democrat Sponsors
1
Republican Sponsors
0
Unaffiliated Sponsors
0
Total Number of Cosponsors
2
Democrat Cosponsors
2
Republican Cosponsors
0
Unaffiliated Cosponsors
0

Policy Area and Potential Impact of Bill HR 4702

Primary Policy Focus

Health

Alternate Title(s) of Bill HR 4702

Securing Gene Synthesis Act
Securing Gene Synthesis Act
To require the Secretary of Health and Human Services to prescribe a regulation reducing the risks in gene synthesis products, and for other purposes.

Comments